-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, Anumana, a nference company, announced that the.
Pulmonary hypertension is a progressive chronic disease affecting 1-1% of the global populati.
Anumana's AI-enhanced ECG algorithm is designed to safely and easily detect early pulmonary hypertensi.
If approved, the early detection algorithm can be downloaded to doctors' smartphones, computers, tablets, or used via the clo.
"Electrophysiological waveforms have enormous untapped potential for early detection of disease, especially for diseases where early diagnosis and treatment can prolong life and alter quality of life," said .
References:
[1] FDA Grants Breakthrough Device Designation to Anumana's ECG Pulmonary Hypertension Early Detection AI Algorit.